TDF 300mg / 3TC 300mg / EFV 400mg, tab.
NST
DORATELE2T-
Valid Article
Account code:
60000
HS Code:
300490
Last Updated on:
07/11/2024, 20:49:27
6.4.2.5 - Fixed-dose combinations of antiretroviral medicines
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
J05AR11
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
TENOFOVIR (TDF) / LAMIVUDINE (3TC)/ EFAVIRENZ (EFV)
Efavirenz (EFV)-based combinations became non-standard. They are no longer the option of choice in first-line HIV treatment according to the WHO guidelines update 2021. Replaced by dolutegravir (DTG)-based combinations.
- In the WHO list of Essential Medicines 2023 (Therapeutic alternative to efavirenz + emtricitabine + tenofovir)
Therapeutic Action
Fixed-dose combination (FDC) of three antiretrovirals:
- nucleotide reverse-transcriptase inhibitors (NRTI): tenofovir + lamivudine
- non-nucleoside reverse transcriptase inhibitor (NNRTI): efavirenz
Indications
HIV infection
Some restricted information has been hidden. Sign in
to see this information
Instructions for use
Storage
Below 25ºC